New York, NY -- (SBWIRE) -- 05/18/2020 -- Acquired immune deficiency syndrome (AIDS) is a retroviral infectious disease caused by human immunodeficiency virus (HIV). HIV attacks the body immune system ideally CD4 cells (T cells), which helps the immune system to fight infections. HIV spreads through body fluids i.e. blood donation and imparting needles to somebody who is HIV infected, and sexual interactions. If HIV is not treated the opportunistic infections like tuberculosis or cancer take advantage of very weak immune system and causes AIDS. The HIV diagnosis can be done by viral load test, saliva test, and blood test. Most accurate test results can obtained by enzyme linked immunosorbent assay (ELISA) test initial stages and western blot method on later stages. Currently, there was no effective cure exists for HIV, but with proper medical care, it can be controlled.

HIV diagnostics market is driven by global increase in prevalence of HIV/AIDS, rise in number of blood transfusions and blood donations, benefits of point-of-care instruments & kits in which patients can be diagnosed even outside the laboratory setting, and increasing government initiatives. In addition, technological advancements in disease diagnostic tests, improvement and commercialization of novel, regulatory approved point of care and rapid CD4, p24 antigen and EID tests are expected to boost the HIV diagnostics market over the forecast period. However, lack of awareness in many undeveloped regions, stringent government regulations and unfavourable reimbursement policies would limit the growth of the market.

Major Key Players of the HIV Diagnostics Market are:
F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Siemens Healthineers) (Germany), Merck KGaA (Germany) Hologic, Inc. (U.S.), Fisher Bioblock Holding II SNC (Thermo-Fisher Scientific) (U.S.),Becton, Dickinson and Company (U.S.),Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.) to name a few.

Get sample copy of "HIV Diagnostics Market" at: https://www.marketgrowthinsight.com/sample/56323?source=shubh

Global HIV diagnosis market is growing at steady state. Government and non-government organizations are also participating in creating and growing awareness related to early HIV diagnosis and available diagnostic tests and equipment. According to WHO, 2015, there is 0.8% prevalence of HIV globally and Sab-Saharan Africa remains most severely affected area with 70% of people for global population. For instance, the unmet requirements in Asia and Africa region for HIV diagnosis, and the government initiatives taken in the region may drive the market for HIV diagnostics. Market players adopting mergers and acquisitions to increase the market position in HIV diagnostics market. In addition, market has a number of pipeline products in accurate and quick diagnosis of HIV few of them are Visitect CD4, Chipcare CD4, and MBIO CD4. Antibody diagnosis test is predominant among the segments. Due to the introduction of point of care products can easily and quickly diagnose disease.

Based on type of test, HIV diagnostics market is segmented into
CD4 count
Antibody test
Viral identification
Viral load
Others

Based on end-user, HIV diagnostics market is segmented into
Hospitals
Diagnostic centers
Blood banks
Home care settings

Research objectives:-

– To study and analyze the global HIV Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data.
– To understand the structure of the HIV Diagnostics market by identifying its various sub-segments.
– Focuses on the key global HIV Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competitive landscape, SWOT analysis, and development plans in the next few years.
– To analyze the HIV Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
– To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Go For Interesting Discount Here: https://www.marketgrowthinsight.com/discount/56323?source=shubh

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 HIV Diagnostics Market Size
2.2 HIV Diagnostics Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 HIV Diagnostics Market Size by Manufacturers
3.2 HIV Diagnostics Key Players Head office and Area Served
3.3 Key Players HIV Diagnostics Product/Solution/Service
3.4 Date of Enter into HIV Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global HIV Diagnostics Sales by Product
4.2 Global HIV Diagnostics Revenue by Product
4.3 HIV Diagnostics Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global HIV Diagnostics Breakdown Data by End User

Have any query? Inquiry about report at: https://www.marketgrowthinsight.com/inquiry/56323?source=shubh

In the end, HIV Diagnostics industry report specifics the major regions, market scenarios with the product price, volume, supply, revenue, production, and market growth rate, demand, forecast and so on. This report also presents SWOT analysis, investment feasibility analysis, and investment return analysis.

About Market Growth Insight
Market Growth Insight 100% Subsidiary of Exltech Solutions India, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 30000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends.

Contact Us-
Email: sales@marketgrowthinsight.com
Phone: + 91 8956767535
Website: https://www.marketgrowthinsight.com